World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
63
Citations
12957
World Ranking
2762
National Ranking
1104

Mark A. Jacobson publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Mark A. Jacobson sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 206 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Mark A. Jacobson D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark A. Jacobson sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 63 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Immune system

Mark A. Jacobson mostly deals with Immunology, Internal medicine, Cytomegalovirus retinitis, Retinitis and Ganciclovir. His Immunology research is multidisciplinary, incorporating perspectives in Asymptomatic and Acquired immunodeficiency syndrome. The study incorporates disciplines such as Gastroenterology, Surgery and AIDS-related complex in addition to Internal medicine.

His research investigates the link between Cytomegalovirus retinitis and topics such as Foscarnet that cross with problems in Herpes simplex virus, Cidofovir, Disease and Endocrinology. His Retinitis research includes themes of Herpesviridae and Pediatrics. As a part of the same scientific study, Mark A. Jacobson usually deals with the Ganciclovir, concentrating on Betaherpesvirinae and frequently concerns with Eye infection.

His most cited work include:

  • Serious Cytomegalovirus Disease in the Acquired Immunodeficiency Syndrome (AIDS): Clinical Findings, Diagnosis, and Treatment (411 citations)
  • Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1 (367 citations)
  • Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. (341 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Immunology, Internal medicine, Acquired immunodeficiency syndrome, Virology and Cytomegalovirus retinitis. His research integrates issues of Gastroenterology, Surgery and Zidovudine in his study of Internal medicine. His work on Sida as part of general Acquired immunodeficiency syndrome research is frequently linked to In patient, thereby connecting diverse disciplines of science.

Mark A. Jacobson has included themes like Aids patients and Antigen in his Virology study. His Cytomegalovirus retinitis study improves the overall literature in Retinitis. His work carried out in the field of Retinitis brings together such families of science as Maintenance therapy, Human cytomegalovirus and Ganciclovir.

He most often published in these fields:

  • Immunology (54.31%)
  • Internal medicine (42.13%)
  • Acquired immunodeficiency syndrome (35.53%)

What were the highlights of his more recent work (between 2004-2020)?

  • Immunology (54.31%)
  • Acquired immunodeficiency syndrome (35.53%)
  • Virology (27.92%)

In recent papers he was focusing on the following fields of study:

Mark A. Jacobson mainly investigates Immunology, Acquired immunodeficiency syndrome, Virology, T cell and CD8. His Immunology study frequently draws connections to other fields, such as Antiretroviral therapy. His studies deal with areas such as Mortality rate, Internal medicine, Disease and Pediatrics as well as Acquired immunodeficiency syndrome.

His Internal medicine study frequently draws connections between adjacent fields such as Gastroenterology. As a member of one scientific family, Mark A. Jacobson mostly works in the field of Virology, focusing on Immunophenotyping and, on occasion, Medical microbiology, Viral replication and Opportunistic infection. He works on Retinitis which deals in particular with Cytomegalovirus retinitis.

Between 2004 and 2020, his most popular works were:

  • Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy (247 citations)
  • Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy. (76 citations)
  • Loss of T cell responses following long-term cryopreservation (69 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Immune system
  • Disease

Mark A. Jacobson focuses on Immunology, Immune system, CD8, Acquired immunodeficiency syndrome and T cell. His work on Immunology is being expanded to include thematically relevant topics such as Virology. While the research belongs to areas of Immune system, he spends his time largely on the problem of Antiretroviral therapy, intersecting his research to questions surrounding Medical microbiology, Immunophenotyping, Opportunistic infection, Discontinuation and Incidence.

His research investigates the connection with CD8 and areas like Human cytomegalovirus which intersect with concerns in Cytomegalovirus vaccine, Adjuvant and Immunogenicity. The Acquired immunodeficiency syndrome study combines topics in areas such as Valganciclovir and Internal medicine. The Cytomegalovirus retinitis research Mark A. Jacobson does as part of his general Retinitis study is frequently linked to other disciplines of science, such as Relative risk, therefore creating a link between diverse domains of science.

Best Publications

  • Serious Cytomegalovirus Disease in the Acquired Immunodeficiency Syndrome (AIDS): Clinical Findings, Diagnosis, and Treatment

    Mark A. Jacobson;John Mills

  • Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.

    Mark A. Jacobson;Michael Zegans;Michael Zegans;Peter R. Pavan;James J. O'Donnell

  • Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1

    Krishna V. Komanduri;Mohan N. Viswanathan;Eric D. Wieder;Diane K. Schmidt

  • Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial

    Richard T. D'Aquila;Michael D. Hughes;Victoria A. Johnson;Margaret A. Fischl

  • Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial.

    Leoung Gs;Feigal Dw;Montgomery Ab;Corkery K

  • Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy

    Peter W. Hunt;Jeffrey N. Martin;Elizabeth Sinclair;Lorrie Epling

  • Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS).

    Mark A. Jacobson;Timothy G. Berger;Senih Fikrig;Paul Becherer

  • Natural History of Disseminated Mycobacterium avium Complex Infection in AIDS

    Jacobson Ma;Hopewell Pc;Yajko Dm;Hadley Wk

  • Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis

    Michael E. Zegans;R. Christopher Walton;Gary N. Holland;James J. O'Donnell

  • Guidelines for the Treatment of Cytomegalovirus Diseases in Patients With AIDS in the Era of Potent Antiretroviral Therapy: Recommendations of an International Panel

    R J Whitley;M A Jacobson;D N Friedberg;G N Holland

  • Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex.

    Mark A. Jacobson;Mark A. Jacobson;Holger Gellermann;Holger Gellermann;Henry Chambers;Henry Chambers

  • 1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus

    Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston

  • Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

    Mark A. Jacobson

  • Phase I Dose Escalation Trial Evaluating the Pharmacokinetics, Anti-Human Cytomegalovirus (HCMV) Activity, and Safety of 1263W94 in Human Immunodeficiency Virus-Infected Men with Asymptomatic HCMV Shedding

    Jacob P. Lalezari;Judith A. Aberg;Laurene H. Wang;Mary Beth Wire

  • Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.

    M A Jacobson;J J O'Donnell;J Mills

  • Mycobacterium avium Complex in the Respiratory or Gastrointestinal Tract and the Risk of M. avium Complex Bacteremia in Patients with Human Immunodeficiency Virus Infection

    Daniel P. Chin;Philip C. Hopewell;David M. Yajko;Eric Vittinghoff

  • Foscarnet Therapy for Ganciclovir-Resistant Cytomegalovirus Retinitis in Patients with AIDS

    M A Jacobson;W L Drew;J Feinberg;J J O'Donnell

  • Natural History and Outcome of New AIDS-Related Cytomegalovirus Retinitis Diagnosed in the Era of Highly Active Antiretroviral Therapy

    Mark A. Jacobson;Mark A. Jacobson;Hopkins Stanley;Hopkins Stanley;Christopher Holtzer;Christopher Holtzer;Todd P. Margolis

  • Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.

    M. A. Jacobson;P. Bacchetti;A. Kolokathis;R. E. Chaisson

  • Foscarnet-Induced Hypocalcemia and Effects of Foscarnet on Calcium Metabolism

    Mark A. Jacobson;John G. Gambertoglio;Francesca T. Aweeka;Dennis M. Causey

Frequent Co-Authors

John Mills
John Mills Monash University
Douglas A. Jabs
Douglas A. Jabs Johns Hopkins University School of Medicine
Gary N. Holland
Gary N. Holland University of California, Los Angeles
Elizabeth Sinclair
Elizabeth Sinclair University of California, San Francisco
Stephen A. Spector
Stephen A. Spector University of California, San Diego
Robert L. Murphy
Robert L. Murphy Northwestern University
Donald I. Abrams
Donald I. Abrams University of California, San Francisco
Paul A. Volberding
Paul A. Volberding University of California, San Francisco
Richard B. Pollard
Richard B. Pollard University of California, Davis
Constance A. Benson
Constance A. Benson University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related fields can broaden career opportunities. Health Information Management is a growing area that intersects with healthcare and technology. Those curious about potential earnings can explore health information management salary insights to understand the financial prospects in this sector.

Many universities now offer flexible learning options, including cahiim accredited him degree online programs. These accredited degrees ensure quality education while accommodating busy schedules, making them ideal for students looking to advance their careers without relocating.

For those seeking quicker credentialing, the shortest online medical billing and coding certificate programs offer accelerated pathways into healthcare administration roles. These certificates provide valuable skills that complement microbiology backgrounds, especially in clinical or laboratory settings.

Additionally, various medical programs online are available, allowing learners to pursue advanced healthcare education remotely. This flexibility enables microbiology students to diversify their expertise and enhance their career paths in the medical field.

Best Scientists Citing Mark A. Jacobson

Trending Scientists

Recently Published Articles